Boosting the body's endocannabinoid system to relieve headaches
Official title: Targeting the Endocannabinoid System for Headache Intervention
Funded at University of Arizona · NIH-11258034 · Data updated 2026-11-12
Researchers are trying to increase natural endocannabinoid levels to reduce migraine and medication-overuse headaches in men and women.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project start | January 1, 2023 |
| Project end | December 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $618,908 |
| NIH project number | 5R01NS126752-04 |
| Project ID | NIH-11258034 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with frequent migraine or medication-overuse headaches, both men and women, would be the likely candidates for therapies this work aims to help.
✕Less likely to help
Patients whose headaches come from structural causes, non–endocannabinoid mechanisms, or who cannot use cannabinoid-related therapies may not benefit from this approach.
What this research studies
This project uses rat models to learn how the brain's endocannabinoid system may drive migraine and medication-overuse headaches. The team measures levels of the natural cannabinoid 2-AG and studies enzymes (ABHD6 and MAGL) that break it down in a pain-regulating brain region called the PAG. They compare male and female animals because early results suggest women may lose 2-AG more readily and show worse headache signals. The goal is to see whether preventing 2-AG breakdown can lower inflammation and headache-related responses and guide new treatment approaches.
Why it matters
Potential benefit: If successful, this work could lead to treatments that boost the body's own cannabinoid signals to reduce headache frequency and severity with fewer side effects than some current drugs.
How similar studies have gone: There are clinical observations and early lab findings suggesting endocannabinoid boosting might help migraine, but direct therapeutic success in people is still limited and largely experimental.
Where this research is happening
-
University of Arizona
Tucson, United States Active
Researchers
- Principal investigator: Milnes, Tally Marie — University of Arizona
- Study coordinator: Milnes, Tally Marie
Related research
Other NIH-funded projects on the same topics.
-
Deep learning approach to diagnosing chronic headaches and facial pain
A new AI-based method aims to improve how doctors diagnose chronic headache and facial pain by using a large, long-term set of patient data.
-
Understanding why some head injuries lead to long-lasting headaches and pain sensations
This grant tests how early inflammation after repeating mild brain injuries might set up long-lasting headaches and widespread pain, using a rat model to study brain circuits involved in pain.
-
Bispecific antibody therapy targeting CGRP and CCL2 for chronic post-traumatic headache
A new non-opioid treatment using a dual-targeting antibody aims to prevent and treat chronic post-traumatic headache in people who have suffered a mild traumatic brain injury.
-
Non-Addictive Nose Spray Nerve Block for Quick Migraine Relief
A new nasal nerve-blocking treatment being tested to relieve migraine attacks quickly without addictive drugs.
-
Pediatric Headache in the COVID era: learning from kids’ pain with smart data and brain signals
A pediatric-focused project uses computer learning and brain-behavior data to better classify headache types in kids and guide personalized treatment.
-
Meningeal nerve signals and immune cells in migraine pain
This NIH grant explores how nerve signals in the brain’s meninges interact with immune cells to trigger migraine pain, with results aimed at improving treatments for people who experience migraines.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.